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Hesperidin, a natural compound, suppresses the epithelial-to-mesenchymal transition through the TGF-β1/
Smad signaling pathway. However, studies on the detailed effects and mechanisms of hesperidin are rare. 
The present study showed that, for A549 alveolar epithelial cells, the anti-proliferative effects of hesperidin 
occurred in a dose-dependent manner, with an IC50= 216.8 μM at 48 h. TGF-β1 was used to activate the 
Smad signaling pathway and induce the epithelial to mesenchymal transition in cells. Treatment with 
hesperidin or SB431542 was used for antagonism of Smad pathway activation. Hesperidin inhibited 
the increase in ɑ-SMA and Col1ɑ-1 and the decrease in E-cadherin in a dose-dependent manner from 
concentration of 20 μM to 60 μM, as assessed by both ELISA and Western blotting assays; however, 
there was no significant effect on cellular morphological alterations. Moreover, the Western blotting 
assay showed that, in the cytoplasm, hesperidin and SB431542 had no significant effect on the protein 
expression of Smad 2, 3, 4, or 7 as well as 2/3. However, 60 μM hesperidin and SB431542 significantly 
decreased p-Smad2/3 protein expression. From the above results, it is concluded that hesperidin can partly 
inhibit the epithelial to mesenchymal transition in human alveolar epithelial cells; the effect accounts for 
the blockage of the phosphorylation of Smad2/3 in the cytoplasm rather than a change in Smad protein 
production in the cytoplasm.
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INTRODUCTION
Idiopathic pulmonary fibrosis (IPF) is a chronic and 
progressive parenchymal lung disease with an incidence 
of 6.8-8.8 cases per 100,000 and a poor prognosis with a 
median survival of only 2-3 years (King, Pardo, Selman, 
2011; Nalysnyk et al., 2012). The pathogenesis of IPF is 
characterized by the formation of fibrotic foci through 
the excessive accumulation of activated fibroblasts and 
myofibroblasts (Selman, Pardo, 2003). Furthermore, there 
is a close link between pulmonary fibrosis and epithelial 
injury. In particular, the injured cells show an E-cadherin 
decrease, an α-SMA increase, and morphological changes, 
appearing to undergo a mesenchymal transition. Currently, 
many reports support that transitional alveolar epithelial 
cells are one of the main sources of fibroblasts and 
myofibroblasts (Kim et al., 2006; Willis et al., 2005).
TGF-β1 is a cytokine that is present at an abnormally 
high level in patients with lung fibrosis, with an obvious 
mesenchymal transition of alveolar epithelial cells, 
indicating TGF-β1 as a possible inducer of epithelial-to-
mesenchymal transition (EMT). In vitro, TGF-β1 induces 
EMT in some alveolar epithelial cells, including A549 
cells, RLE-6TN cells (Gao et al., 2017) and primary 
alveolar epithelial cells (Kim et al., 2006). Therefore, the 
TGF-β1-induced EMT model has been widely applied to 
understand the efficacy and mechanism of drugs against 
pulmonary fibrosis (Baek et al., 2016; Coward, Saini, 
Jenkins, 2010; Yang, Chen, Sun, 2013; Yu et al., 2016a).
Hesperidin is a flavonoid glycoside that is 
abundant in oranges and lemons and has a wide range of 
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pharmacological activities, including anti-inflammatory, 
anti-viral, and anticancer activities (Iranshahi et al., 
2015). Recently, some studies reported that hesperidin 
inhibits liver fibrosis through the Wnt/β-catenin pathway 
(Lin et al., 2015) and the TGF-β1/Smad signaling 
pathway (Wu et al., 2015). Furthermore, in a bleomycin-
induced pulmonary fibrosis rat model, hesperidin shows 
a beneficial effect (Görmeli Cemile Ayse et al., 2016). 
In our study, hesperidin showed an inhibitory effect 
on EMT induced by TGF-β1 in A549 cells (Yu et al., 
2016a). However, the detailed mechanism of hesperidin 
in blocking the TGF-β1 signaling pathway is still unclear.
Smad proteins are the intracellular kinase-substrate 
of TGF-β1-receptor complexes, with molecular weights 
ranging from 42-60 kD, and are mainly located in the 
cytoplasm, transmitting signals from the membrane to the 
nucleus of the TGF-β1 signaling pathway. The levels of 
Smad protein synthesis and Smad phosphorylation have 
pivotal effects on signal transduction. Therefore, in this 
study, Smad protein expression, including the expression 
of Smad 2, Smad 3, Smad 4, Smad 2/3, Smad7, and 
p-Smad 2/3 in the cytoplasm, was assayed to explore the 
mechanism of hesperidin in A549 cells undergoing EMT.
MATERIAL AND METHODS
Hesperidin
Hesperidin was purchased from the Chengdu Must 
Bio-Technology Co., Ltd. (Chengdu, Sichuan province, 
China), dissolved in DMSO as a 200 mM stock solution 
and stored at -20 °C.
Reagents and assay kits
Recombinant human TGF-β1 was purchased from 
Pepro Tech Ltd. (Rocky Hill, NJ, USA). SB431542 was 
purchased from Sigma-Aldrich (St. Louis, MO, USA). The 
Cell Counting Kit-8 was purchased from Beijing Solarbio 
Science & Technology Co., Ltd (Beijing, China). The 
human soluble ECAD ELISA Kit was purchased from 
Boster Biological Technology Co., Ltd. (Wuhan, Hubei 
province, China). The human Col-1α and α-SMA ELISA 
Kits were purchased from Cloud-Clone Corp (Wuhan, 
Hubei province, China).
Cell culture
A549 cells were purchased from the Institute of 
Biochemistry and Cell Biology, Shanghai Institutes for 
Biological Sciences of Chinese Academy of Sciences 
(Shanghai, China). RPMI1640 medium was purchased 
from Beijing Solarbio Science & Technology Co., 
Ltd, China (Beijing, China). Fetal bovine serum (FBS) 
was purchased from Zhejiang Tian Hang Biological 
Technology Co., Ltd (Huzhou, Zhejiang province, 
China). The cells were cultured in RPMI1640 medium 
containing 10% FBS and incubated at 37°C in a humidified 
atmosphere containing 5% CO2. Once the cells reached 
80% confluence, they were used for the experiments.
Cell proliferation assay
The cells were seeded at 5,000 cells per well in 
a 96-well plate. After 24 h, the medium was changed 
to RPMI1640 medium with 0.1% FBS for 12 h. Then, 
the cells were incubated with fresh RPMI1640 medium 
containing 10% FBS or a combination of different 
concentrations of hesperidin (40- 200 μM). At 24 h, 36 h 
or 48 h, the cellular proliferation assay was performed 
by the addition of 10 μL CCK-8 solution to each well, 
followed by an incubation at 37 °C for 2 h. The absorbance 
(A) was measured at a wavelength of 450 nm using a 
microplate reader. All of the experiments were performed 
in quintuplicate. The cells without drug treatment were 
used as controls. The inhibition rate was calculated as 
follows:
Treatment with TGF-β1 and hesperidin
The cells were seeded at 50,000 cells per well in 
a 24-well plate. After 24 h, the medium was changed 
to RPMI1640 medium with 0.1% FBS for 12 h. Then, 
the cells were incubated with fresh RPMI1640 medium 
containing 10% FBS or a combination of 7.5 ng/mL 
TGF-β1 with different concentrations of hesperidin (0, 
20, 40, and 60 μM) for 48 h. 
Roundness assay of cellular morphology
At 48 h, the cells were assessed using a phase 
contrast microscope (Eclipse MV/TS 100LED-F MV 
Inverted microscope, Nikon, Tokyo, Japan), and images 
were captured in three arbitrary fields in a well by a 
digital camera. The images were saved on a computer 
and finally measured and analyzed for cellular shape in 
accordance with previous methods (Ren et al., 2015). 
Adobe Photoshop CS2 software (Adobe Systems Inc., San 
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Jose, CA, USA) was used for selecting, depicting shape 
and segmenting the cells in the images. Subsequently, 
Image Pro Plus 6.0 software (Media Cybernetics Inc., 
Rockville, MD, USA) was applied for calculating the 
roundness of the cells.
ELISA assay
After image acquirement, the medium was removed 
and centrifuged at 3000 rpm and 4 °C for 10 min. The 
cells were washed with PBS. Then, trypsin was added, 
and the cells were harvested with medium containing 10% 
FBS. After centrifugation of the cells with the medium at 
1200 rpm and 4 °C for 5 min, the cell pellet was obtained 
and then lysed with 1% TritonX-100, 137 mmol/L NaCl, 
20 mmol/L Tris-HCl,2 mmol/L EDTA, and 1 mmol/L 
PMSF. The lysates were centrifuged at 3500 rpm and 4 °C 
for 10 min, and the supernatant was stored at 4 °C. The 
supernatant was assayed for E-cad, Col-1a and ɑ-SMA 
according to the manufacturer’s protocol. The protein 
concentration in the supernatant was measured by a BCA 
kit.
Preparation of cytoplasm protein
The cells were plated at a density of 100,000 cells 
per well in a 60 mm dish. The cells were treated with 
7.5 ng/mL TGF-β1 and various concentrations of 
hesperidin (0, 20, 40, and 60 μM) or 10 μM SB431542 
as described above. After centrifugation, the cells were 
lysed with a Membrane and Cytosol protein extraction kit 
(Beyotime Biotechnology, Shanghai, China) after adding 
PMSF and were frozen at -70 °C. Next, the cells were 
thawed at room temperature. The freeze-thaw cycles were 
carried out 3 times to obtain up to a 90% broken cell ratio. 
Then, the lysates were centrifuged at 12000 g for 30 min at 
4 °C, and the supernatant was extracted to obtain the total 
cytoplasm protein for the Western blotting assay.
Western blot analysis
The protein concentration in the supernatant 
was measured by a BCA kit. The total protein (30 or 
50 μg) from a sample was separated by SDS-PAGE 
and transferred onto a PVDF membrane (Millipore 
Corp., Billerica, MA, USA). Then, the membranes were 
incubated in TBST containing 5% skim milk at room 
temperature for 2 h. After blocking, the membranes 
were incubated with specific primary antibodies at 4 °C 
overnight. The rabbit polyclonal anti-Smad 2, 3, 4, 7 and 
2/3 antibodies (Boster Biological Technology Co., Ltd. 
Wuhan, Hubei province, China) were diluted 1:100. The 
rabbit polyclonal anti-p-Smad2/3 (Abcam, Cambridge, 
MA, USA) and rabbit polyclonal anti-GAPDH (Boster 
Biological Technology Co., Ltd. Wuhan, Hubei province, 
China) antibodies were diluted 1:400. The next day, the 
membranes were washed 3 times with TBST, followed 
by incubation in goat anti-rabbit IgG conjugated with 
horseradish peroxidase antibody (Boster Biological 
Technology Co., Ltd. Wuhan, Hubei province, China) 
for 2 h at room temperature. Finally, the membranes were 
washed another 3 times. The proteins were visualized with 
an ECL-chemiluminescent kit and were detected by the 
Chemi Doc MP Imaging system (Bio-RAD, Hercules, 
CA, USA). The expression of GAPDH was used as the 
loading control.
Statistical analyses
All the data are expressed as the mean ± standard 
error of the mean (SEM). The significance of the differences 
between groups was assessed by a one-way analysis of 
variance (ANOVA) using SPSS 16.0. Differences with a 
p-value of < 0.05 were considered statistically significant. 
The IC15 and IC50 values of hesperidin were calculated 
using GraphPad Prism5 software.
RESULTS
Hesperidin inhibited the proliferation of A549 
cells
As shown in Figure 1, hesperidin had an anti-
proliferative effect on A549 cells, with dose-dependent 
decreases in cell proliferation (40-200 μM). The inhibitory 
effect started at 24 h, was sustained for 48 h and was 
the strongest at 36 h. The IC50 values of hesperidin 
were 338.9±2.45 μM at 24 h, 153.3±1.76 μM at 36 h, 
and 216.8±2.02 μM at 48 h. The IC15 value at 48 h was 
60.26 μM, and the approximate value of 60 μM was chosen 
as the highest dose in the following study.
Hesperidin inhibited the TGF-β1-induced epithelial 
to mesenchymal transition in A549 cells
To determine whether hesperidin acts as an EMT 
inhibitory compound in A549 cells, TGF-β1-induced 
EMT was carried out. The ELISA assay results showed 
that hesperidin inhibited the decreased E-cad protein level 
in a dose-dependent manner, and the 60 μM hesperidin 
treatment yielded a significant E-cad increase than the 
TGF-β1 control (Figure 2B). Hesperidin also reduced 
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Hesperidin decreased p-Smad2/3 expression in 
TGF-β1-stimLuated cells 
Previous  repor ts  indicated that  Smad 2/3 
phosphorylation in the cytoplasm is an essential step 
in signal transduction (Valcourt et al., 2005; Willis, 
DuBois, Borok, 2006). We therefore investigated 
whether hesperidin exerted an inhibitory effect on 
EMT via the modulation of Smad 2/3 phosphorylation. 
As expected, TGF-β1 treatment promoted Smad 2/3 
phosphorylation in the cytoplasm, but SB431542 
inhibited the phosphorylation. Hesperidin also inhibited 
the phosphorylation in a dose-dependent manner, with a 
12.1%, 37.0% and 46.3% decrease in phospho-Smad2/3 
at 20 μM, 40 μM, and 60 μM concentration, respectively, 
suggesting that the anti-EMT capacity of hesperidin was 
relative to the inhibition of Smad2/3 phosphorylation in 
the cytoplasm. Furthermore, the inhibition was not relative 
to Smad2/3 production in the cytoplasm because there was 
no obvious difference in Smad 2/3 protein expression in 
the cells (Figure 4). 
DISCUSSION
More evidence supports the EMT of alveolar 
epithelial cells as playing a central role in the pathogenesis 
of pulmonary f ibrosis  (Derynck,  Zhang,  2003; 
Gorowiec et al., 2012; Coward, Saini, Jenkins, 2010). 
Alveolar basement membrane disruption and alveolar 
injury lead to TGF-β1 activation and secretion, and, 
subsequently, TGF-β1 deteriorates EMT in alveolar 
epithelial cells (Coward, Saini, Jenkins, 2010). In vitro, 
TGF-β1-induced EMT in alveolar cells has been applied 
in many studies of IPF (Baek et al., 2016; Yang, Chen, 
Sun, 2013; Yu, et al., 2016b). In this study, A549 cells, 
stimulated by TGF-β1, showed an obvious EMT, including 
cellular morphology changes from cobblestone to spindle, 
an E-cad decrease and an α-SMA increase, which were 
similar to the results of previous studies (Baek, et al., 2016; 
Yang, Chen, Sun, 2013; Yu et al., 2016b).
Hesperidin, a flavonoid glycoside that is extracted 
from the fruit peels of the genus citrus, suppresses injury or 
fibrosis of some organs in vivo. These studies have mainly 
focused on anti-liver fibrosis, including the inhibition of 
dimethylnitrosamine-induced and CCl4-induced fibrosis in 
rats (Elshazly, Mahmoud, 2014; Pérez-Vargas et al., 2014). 
The anti-liver fibrosis mechanism of hesperidin is complex 
and includes the Wnt/β-catenin pathway (Lin et al., 
2015), the PTEN/AKT pathway (Li et al., 2017), and the 
TGF-β1/Smad signaling pathway (Pérez-Vargas et al., 
2014; Wu et al., 2015). Recently, some reports show the 
FIGURE 1 - Inhibition of hesperidin in A549 cell proliferation. 
The cells were treated with various concentrations of hesperidin 
for 24 h, 36 h and 48 h. Cells without hesperidin treatment were 
used as controls (0 μM hesperidin). *p < 0.05 and **p < 0.01 
compared to the control group.
α-SMA and Col-1α levels in a dose-dependent manner, 
and the 40 and 60 μM hesperidin treatments yielded a 
significant decrease in α-SMA and Col-1α levels than the 
TGF-β1 control (Figure 2C; 2D). The inhibitory effect 
was confirmed by the subsequent Western blotting assay 
results (Figure 2E; 2F). However, hesperidin did not 
significantly inhibit the decrease in roundness. These data 
suggested that hesperidin had a partial inhibitory effect 
on EMT. 
Hesperidin had no effect on Smad 2, 3, 4 and 
7 protein synthesis in A549 cells stimulated by 
TGF-β1
Since the Smad family of proteins are key intracellular 
mediators of signal transduction in TGF-β1-induced EMT, 
the signal transduction efficiency is influenced by changes 
in Smad protein production in the cytoplasm. Therefore, 
we evaluated hesperidin efficacy on important Smad 
protein expression levels in the cytoplasm, including 
on Smad 2, 3, 4 and 7 expression levels, by a Western 
blotting assay. SB431542, a potent and specific inhibitor 
of the TGF-β1 type 1 actin receptor, was also used as a 
positive control for the inhibition of Smad activation. As 
shown in Figure 3, the A549 cells treated with hesperidin 
(20-60 μM) or SB431542 for 48 h showed no significant 
difference in the expression of these proteins compared to 
those with the TGF-β1 treatment. The results suggested 
that hesperidin might have no effect on the synthesis of 
these Smad proteins.
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protective effect of hesperidin against pulmonary injury 
induced by endotoxin, intestinal ischemia/reperfusion or 
lipopolysaccharide in rats or mice (Bayomy et al., 2014; 
Liu et al., 2015; Yeh et al., 2007), suggesting the possible 
action of anti-pulmonary fibrosis of hesperidin. In one study, 
hesperidin increased E-cadherin and decreased α-SMA and 
Col-1α, thus appearing to inhibit EMT, which was similar 
to the result of our previous study (Yu et al., 2016a).
Exogenous TGF-β1 binds and activates TβRII and 
then forms heteromeric complexes of type I and type II 
serine/threonine kinase receptors, finally activating TβRI 
receptor kinases and the Smad signaling cascade. Smad 
proteins are mainly located in the cytoplasm and consist 
of a highly conserved family of signaling transducers. 
Smad proteins are divided into three subfamilies, including 
receptor-activated Smads (R-Smads), which include 
FIGURE 2 - Effect of hesperidin on the epithelial to mesenchymal transition. (A). The cells were treated with TGF-β1 (7.5 ng/mL) 
and various concentrations of hesperidin (0-60 μM) for 48 h. After TGF-β1 treatment, the cell morphology changed from a pebble-
like shape to an elongated shape (magnification 100 ×). (B-D). Hesperidin did not significantly inhibit a decrease in the roundness 
value but significantly inhibited the downregulation of E-cad and the upregulation of α-SMA and Col-1α in a dose-dependent 
manner, as determined by ELISA assays. (E and F). The Western blotting assays evaluated the effect of hesperidin on Col-1ɑ and 
ɑ-SMA protein expression. Lanes 1, 2, 3, 4, 5 and 6 represent the normal control, TGF-β1 control, SB431542+TGF-β1, 20 μM 
heperidin+TGF-β1, 40 μM heperidin+TGF-β1 and 60 μM heperidin+TGF-β1 groups, respectively. The GADPH expression was 
the loading control. The quantitative data, expressing the corresponding proteins levels, were assessed using densitometry and are 
expressed in relative intensity arbitrary units in the panels. The bar represents the standard error of the mean (n = 5). *p < 0.05 and 
**p < 0.01 compared to the TGF-β1control group. 
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Smad1, Smad2, Smad3, Smad5, and Smad8, common 
mediator Smads (Co-Smads), such as Smad4, which 
oligomerizes with activates R-Smads, and inhibitory 
Smads (I-Smads), such as Smad6 and Smad7, which have 
a negative feedback effect by competing with R-Smads 
for receptor interaction and by marking receptors for 
degradation (Moustakas, Souchelnytskyi, Heldin, 2001). 
For the TGF-β/Smad signaling pathway in the cytoplasm, 
the key transducers are Smad 2, Smad 3, Smad 4 and 
Smad 7. Obviously, changes in these protein levels in the 
cytoplasm intervene in TGF-β/Smad signal transduction. 
Some reports show that the inhibition of Smad3 expression 
reduces the TGF-β-mediated induction of EMT, and small 
molecule inhibitors of Smad3 have clinical potential in 
the treatment of fibrotic diseases (Flanders, 2004; Liu, 
2006). Interestingly, hesperidin reduces Smad 2 and Smad 
3 mRNA and increases Smad 7 mRNA in PDGF-induced 
HSC-T6 cells (Wu et al., 2015). However, in this study, 
hesperidin did not obviously intervene in these protein 
levels, suggesting that the hesperidin inhibitory effect on 
TGF-β/Smad signal transduction in A549 cells may be 
related to another mechanism.
In TGF-β1/Smad signal transduction, p-Smad2/3 
formation through the phosphorylation of the C-terminal 
serine residues in R-Smads by type I receptor kinases 
is a crucial step that is followed by the formation of an 
oligomeric complex with the Co-Smads and Smad4 
(Moustakas, Souchelnytskyi, Heldin, 2001). The 
oligomeric complex translocates into the nucleus, binds to 
specific genes and results in protein expression changes. 
HDND-7, a derivative of hesperidin, significantly 
attenuates liver fibrosis and inhibits the activation and 
proliferation of PDGF-induced HSCs, including a 
decrease in the expression levels of p-Smad3 and Smad4, 
through not only the Wnt/β- catenin pathway but also the 
TGF-β/Smad pathway (Lin et al., 2015). In this study, the 
p-Smad2/3 protein expression level was increased 1.42-
fold in the A549 cells stimulated by TGF-β1 compared 
to the unstimulated cells. Compared with the TGF-β1 
stimulated cells, hesperidin decreased p-Smad2/3 in 
FIGURE 3 - Effect of hesperidin on the synthesis of Smad proteins in the cytoplasm. Lanes 1, 2, 3, 4, 5 and 6 represent the 
normal control, TGF-β1 control, 10 μM SB431542+ TGF-β1, 20 μM heperidin+ TGF-β1, 40 μM heperidin+TGF-β1 and 60 μM 
heperidin+TGF-β1 groups, respectively. The GADPH expression was the loading control. The quantitative data, expressing the 
corresponding Smad protein levels, were assessed using densitometry and are expressed in relative intensity arbitrary units in the 
panels. The bar represents the standard error of the mean (n = 5). 
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FIGURE 4 - Effect of hesperidin on Smad 2/3 phosphorylation in the cytoplasm. Lanes 1, 2, 3, 4, 5 and 6 represent the normal control, 
TGF-β1 control, SB431542+TGF-β1, 20 μM heperidin+TGF-β1, 40 μM heperidin+TGF-β1 and 60 μM heperidin+TGF-β1 groups, 
respectively. The GADPH expression was the loading control. The quantitative data, expressing the corresponding Smad proteins 
level, were assessed using densitometry and are expressed in relative intensity arbitrary units in the panels. The bar represents the 
standard error of the mean (n = 5). *p < 0.05 and **p < 0.01 compared to the TGF-β1control group.
FIGURE 5 - Cartoon of the inhibitory effect of hesperidin on TGF-β1-induced EMT through the Smad pathway in the cytoplasm.
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a dose-dependent manner. The results suggested that 
the inhibitory effect of hesperidin on TGF-β1 signal 
transduction might be associated with its suppressive 
effect on the phosphorylation of R-Smads or the formation 
of oligomeric complexes, such as p-Smad2/3.
Excessive alpha smooth muscle actin (ɑ-SMA) 
expression is a hallmark of activated fibroblasts and 
myofibroblasts (Desmoulière, et al., 1993; Sanders, 
Kumbla, Hagood, 2007). These cells, in a high ɑ-SMA 
expression state, have an excessive ability to synthesize 
and secrete extracellular matrix proteins, such as collagens 
(Col), resulting in the formation of fibrotic foci and 
abnormal structures in pulmonary tissue, which is one 
of the key pathological mechanisms in IPF. The TGF-β/
Smad pathway partly regulates the synthesis and secretion 
of two proteins (Hu, Wu, Phan, 2003; Zhou et al., 2011). 
Hesperidin significantly decreases ɑ-SMA and Col-1ɑ 
proteins level, further supporting that the inhibition of the 
Smad pathway activity could be an important mechanism 
of hesperidin in anti-pulmonary fibrosis. 
Collectively, our present study suggested that the 
anti-EMT mechanism of hesperidin was partly mediated 
by the inhibition of Smad2/3 phosphorylation of the 
TGF-β/Smad pathway in the cytoplasm. Thus, hesperidin 
may provide a potential new therapeutic strategy for the 
treatment of pulmonary fibrosis.
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